DK3183237T3 - Fremgangsmåde til fremstilling af 5-fluor-1h-pyrazoler startende ud fra hexafluorpropen - Google Patents

Fremgangsmåde til fremstilling af 5-fluor-1h-pyrazoler startende ud fra hexafluorpropen Download PDF

Info

Publication number
DK3183237T3
DK3183237T3 DK15756864.3T DK15756864T DK3183237T3 DK 3183237 T3 DK3183237 T3 DK 3183237T3 DK 15756864 T DK15756864 T DK 15756864T DK 3183237 T3 DK3183237 T3 DK 3183237T3
Authority
DK
Denmark
Prior art keywords
hexafluorprop
fluoro
preparing
procedure
pyrazoles
Prior art date
Application number
DK15756864.3T
Other languages
English (en)
Inventor
Sergii Pazenok
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Application granted granted Critical
Publication of DK3183237T3 publication Critical patent/DK3183237T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/35Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
    • C07C17/358Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction by isomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK15756864.3T 2014-08-19 2015-08-14 Fremgangsmåde til fremstilling af 5-fluor-1h-pyrazoler startende ud fra hexafluorpropen DK3183237T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14181402 2014-08-19
PCT/EP2015/068782 WO2016026789A1 (en) 2014-08-19 2015-08-14 Process for the preparation of 5-fluoro-1h-pyrazoles starting from hexafluoropropene

Publications (1)

Publication Number Publication Date
DK3183237T3 true DK3183237T3 (da) 2019-10-21

Family

ID=51357834

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15756864.3T DK3183237T3 (da) 2014-08-19 2015-08-14 Fremgangsmåde til fremstilling af 5-fluor-1h-pyrazoler startende ud fra hexafluorpropen

Country Status (18)

Country Link
US (1) US10059673B2 (da)
EP (1) EP3183237B1 (da)
JP (1) JP6676038B2 (da)
KR (1) KR102540220B1 (da)
CN (1) CN107108516A (da)
AU (1) AU2015306261B2 (da)
DK (1) DK3183237T3 (da)
ES (1) ES2750353T3 (da)
HR (1) HRP20191837T1 (da)
HU (1) HUE045718T2 (da)
IL (1) IL250441B (da)
LT (1) LT3183237T (da)
MX (1) MX369501B (da)
PL (1) PL3183237T3 (da)
PT (1) PT3183237T (da)
SI (1) SI3183237T1 (da)
TW (1) TW201619139A (da)
WO (1) WO2016026789A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
WO2016174049A1 (en) * 2015-04-30 2016-11-03 Bayer Animal Health Gmbh Anti-parasitic combinations including halogen-substituted compounds
CN105646355A (zh) * 2016-04-07 2016-06-08 戊言医药科技(上海)有限公司 3-(羟甲基)-1-甲基-吡唑-5-甲腈的制备方法
WO2018162312A1 (en) 2017-03-10 2018-09-13 Basf Se Spirocyclic derivatives
CN108383681B (zh) * 2018-03-19 2021-05-18 浙江巨化技术中心有限公司 一种全氟-2-甲基-2-戊烯的制备方法
CN109574812B (zh) * 2018-12-24 2021-08-13 天津长芦新材料研究院有限公司 高选择性制备全氟烯烃的方法
EP3771711A1 (en) 2019-07-29 2021-02-03 Bayer Animal Health GmbH Pyrazole derivatives for controlling arthropods
AU2020328863A1 (en) 2019-08-14 2022-04-07 Vetoquinol Sa Compositions comprising tigolaner for controlling parasites
KR20230016672A (ko) 2020-05-27 2023-02-02 비토퀴놀 에스에이 2-클로로-n-(1-시아노사이클로프로필)-5-[2'-메틸-5'-(펜타플루오로에틸)-4'-(트리플루오로메틸)-2'h-1,3'-비피라졸-4-일]벤즈아미드의 제조 방법
WO2021242581A1 (en) 2020-05-29 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918501A (en) 1958-02-27 1959-12-22 Du Pont Internally unsaturated perfluoroolefins and preparation thereof
JPS52108911A (en) 1976-03-05 1977-09-12 Central Glass Co Ltd Isomerization of hexafluoropropene oligomers
US4377717A (en) 1981-12-14 1983-03-22 Allied Corporation Method for the production of perfluoro-2-methylpentene-2
DE4228592A1 (de) 1992-08-27 1994-03-03 Hoechst Ag Verfahren zur Herstellung von Hexafluorpropen-Dimeren mit einem hohen Anteil an Perfluor-(4-methyl-2-penten)
US5254774A (en) 1992-12-28 1993-10-19 Minnesota Mining And Manufacturing Company Preparation of hexafluoropropene oligomers
ATE430729T1 (de) 2003-10-08 2009-05-15 Lilly Co Eli Pyrrol- und pyrazolderivate als potentiatoren von glutamatrezeptoren
US8642788B2 (en) 2008-01-11 2014-02-04 The Regents Of The University Of California Activators of executioner procaspases 3, 6 and 7
EP2184273A1 (de) * 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
US20100291151A1 (en) 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
TW201107296A (en) * 2009-07-31 2011-03-01 Syngenta Participations Ag Processes for the alkylation of pyrazoles
EP2643302A1 (en) 2010-11-23 2013-10-02 Syngenta Participations AG Insecticidal compounds
GB201102289D0 (en) 2011-02-09 2011-03-23 Syngenta Participations Ag New use
CN103354811A (zh) * 2011-02-09 2013-10-16 先正达参股股份有限公司 杀虫化合物
CN103483139B (zh) 2012-06-15 2016-01-27 中化蓝天集团有限公司 一种制备全氟-2-甲基-2-戊烯的方法
CN104470900B (zh) * 2012-07-19 2016-10-19 拜尔农作物科学股份公司 5-氟-1h-吡唑的制备方法
ES2656012T3 (es) * 2013-02-06 2018-02-22 Bayer Cropscience Aktiengesellschaft Derivados de pirazol sustituidos con halógeno como pesticidas

Also Published As

Publication number Publication date
HUE045718T2 (hu) 2020-01-28
EP3183237A1 (en) 2017-06-28
WO2016026789A1 (en) 2016-02-25
US20170233348A1 (en) 2017-08-17
PL3183237T3 (pl) 2020-03-31
KR20170042732A (ko) 2017-04-19
KR102540220B1 (ko) 2023-06-02
SI3183237T1 (sl) 2020-01-31
LT3183237T (lt) 2019-10-25
IL250441A0 (en) 2017-03-30
MX2017002214A (es) 2017-05-22
US10059673B2 (en) 2018-08-28
AU2015306261B2 (en) 2020-03-05
IL250441B (en) 2019-10-31
JP2017525707A (ja) 2017-09-07
JP6676038B2 (ja) 2020-04-08
EP3183237B1 (en) 2019-07-24
MX369501B (es) 2019-11-11
BR112017002773A2 (pt) 2018-07-17
CN107108516A (zh) 2017-08-29
AU2015306261A1 (en) 2017-03-09
PT3183237T (pt) 2019-10-28
HRP20191837T1 (hr) 2019-12-27
TW201619139A (zh) 2016-06-01
ES2750353T3 (es) 2020-03-25

Similar Documents

Publication Publication Date Title
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3165507T3 (da) Fremgangsmåde til fremstilling af porøs grafen
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3757214T3 (da) Sammensætninger til modulering af sod-1-ekspression
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3372585T3 (da) Fremgangsmåde til fremstillingen af en diarylthiohydantoinforbindelse
DK3183237T3 (da) Fremgangsmåde til fremstilling af 5-fluor-1h-pyrazoler startende ud fra hexafluorpropen
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3126373T3 (da) Fremgangsmåde til fremstilling af amg 416
DK3160927T3 (da) Fremgangsmåde til fremstilling af ethylenglycol ud fra sukker
DK3122444T3 (da) Fremgangsmåde til fremstilling af membraner
DK3152176T5 (da) Fremgangsmåde til fremstillingen af en cementforbindelse
DK3125898T3 (da) Farmakofor til trail-induktion
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3148984T3 (da) Fremgangsmåde til fremstilling af 5-fluor-1h-pyrazoler startende ud fra hexafluorpropen
DK3229995T3 (da) Fremgangsmåde for fremstilling af et endestykke
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3461806T3 (da) Fremgangsmåde til fremstilling af alfa-hydroxymethionin-analoger ud fra sukker
DK3191498T3 (da) Fremgangsmåde til fremstilling af 2'-o-fucosyllactose
DK3166611T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer
DK3152191T3 (da) Forbedret fremgangsmåde til fremstilling af duocarmycin-prodrugs
DK3274143T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer